Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.
Saved in:
| Title: | Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab. |
|---|---|
| Authors: | Fuja C; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Kothary V; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, USA., Carll TC; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Singh S; American Red Cross, National Reference Laboratory for Blood Group Serology, Philadelphia, Pennsylvania, USA., Mansfield P; American Red Cross, National Reference Laboratory for Blood Group Serology, Philadelphia, Pennsylvania, USA., Wool GD; Department of Pathology, University of Chicago, Chicago, Illinois, USA. |
| Source: | Transfusion [Transfusion] 2022 Jul; Vol. 62 (7), pp. 1446-1451. Date of Electronic Publication: 2022 May 30. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2995 (Electronic) Linking ISSN: 00411132 NLM ISO Abbreviation: Transfusion Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-2995 |
|---|---|
| DOI: | 10.1111/trf.16932 |
